CEO Total Pay
$284K
FY2021 Summary Compensation, below median
The CEO earned $284K in FY2021 against median worker pay of $283,758 · Chemicals & Pharmaceuticals.
Data updated August 2026
Latest filing FY2021. This company's newest DEF 14A on file is for FY2021, not FY2025, so the figures on this page are from that earlier year and are not ranked against the FY2025 industry benchmark. Industry pages mark issuers like this one with a "Latest filing" label.
Answer first
Figures come from Section 953(b) Dodd-Frank DEF 14A disclosures - not estimates. View all Chemicals & Pharmaceuticals companies.
Exclusive CEO-to-median-worker bands across 153 complete latest-FY filings in SIC 28. Segments sum to the peer set, not this company's compensation pillar.
A component-level pay breakdown is not reported in Exelixis, Inc.'s structured SEC pay-ratio disclosure. See our methodology →
Exelixis, Inc. disclosed 27:1 CEO-to-worker pay and $284K CEO total in FY2021. the CEO earned 27× the median employee ($283,758) in FY2021.
Median employee $283,758 (ELITE-MED); MODEST · MICRO stamps put about 27 median-wage years per CEO year.
CEO Total Pay
$284K
FY2021 Summary Compensation, below median
Pay Ratio
27:1
Below typical
Exelixis, Inc. disclosed 27:1 CEO-to-worker pay and $284K CEO total in FY2021. The structured pay-ratio disclosure reports the total without line-item components. Chemicals & Pharmaceuticals (SIC 28) median ratio is 42:1 across 168 FY2025 filers; Exelixis, Inc.'s $284K CEO total is at or below the $7.9M industry median CEO pay.
Exelixis, Inc. stamps MODEST · MICRO · ELITE-MED; grant-date fair value (not realized pay) is what the DEF 14A reports. Open Chemicals & Pharmaceuticals peers.
Read our methodology - how this data is sourced, computed, and verified. Exelixis, Inc. disclosed 27:1 CEO-to-worker pay and $284K CEO total in FY2021.
ABS(ceo_total_comp) peers first, then a SIC pole and a stamp-branched guide - not a fixed Related strip. This page stamps MODEST · MICRO · ELITE-MED.
ABS(ceo_total_comp) peer at $283K (Δ $426 lighter vs Exelixis, Inc.); FLOOR · HIGH-MED vs this page's MODEST · MICRO · ELITE-MED.
ABS(ceo_total_comp) peer at $281K (Δ $3K lighter vs Exelixis, Inc.); FLOOR · ELITE-MED vs this page's MODEST · MICRO · ELITE-MED.
ABS(ceo_total_comp) peer at $280K (Δ $3K lighter vs Exelixis, Inc.); FLOOR · HIGH-MED vs this page's MODEST · MICRO · ELITE-MED.
ABS(ceo_total_comp) peer at $288K (Δ $5K heavier vs Exelixis, Inc.); FLOOR · HIGH-MED vs this page's MODEST · MICRO · ELITE-MED.
Exelixis, Inc. stamps MODEST · MICRO · ELITE-MED inside SIC 28 - open the industry median board after the ABS peers.
See where MODEST · MICRO packages sit on the national leaderboard after reading Exelixis, Inc..
Exelixis, Inc.'s MODEST stamp sits in the lower Item 402(u) band - start with how the ratio is disclosed before comparing peers.
Data currency: Executive compensation from SEC EDGAR DEF 14A proxy statements through fiscal year 2025, compiled and last refreshed August 2026. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.